Categories
Cipla Limited — Important, 30-10-2024: General Updates
30-10-2024 · 09:33 pm
Cipla Ltd. announced that the recent USFDA inspection of its manufacturing facility in Goa has been classified as Voluntary Action Indicated (VAI). This follows a routine current Good Manufacturing Practices (cGMP) inspection that took place from June 10 to June 21, 2024. The company has formally communicated this update to the relevant stock exchanges.
No comments yet. Be the first to comment!